Near-infrared fluorescence-guided resection of micrometastases derived from esophageal squamous cell carcinoma using a c-Met-targeted probe in a preclinical xenograft model-Reference-Cited by-同舟云学术

Near-infrared fluorescence-guided resection of micrometastases derived from esophageal squamous cell carcinoma using a c-Met-targeted probe in a preclinical xenograft model

Published:2021-04 Issue: Volume:332 Page:171-183
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Liang Mingzhu,Yang Meilin,Wang Fen,Wang Xiaojin,He Bailiang,Mei Chaoming,He Jianzhong,Lin Yujing,Cao Qingdong,Li Dan,Shan Hong

Funder

National Natural Science Foundation of China

Guangdong Medical Research Foundation

National Key Research and Development Program of China

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference46 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018

2. Global incidence of oesophageal cancer by histological subtype in 2012;Arnold;Gut.,2015

3. NCCN guideline for Esophageal and Esophagogastric Junction Cancers, https://www.nccn.org/professionals/physician_gls/default.aspx#esophageal. (accessed on 28.10.20).

4. Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world;Siewert;Ann. Surg.,2001

5. Risk factors for local recurrence and optimal length of esophagectomy in esophageal squamous cell carcinoma;Kang;Ann. Thorac. Surg.,2016

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perioperative outcomes and survival of indocyanine green guided minimally esophagectomy in patients with esophageal cancer: a retrospective comparison study;2024-07-08

2. Synthesis and Evaluation of a Novel c-Met-Targeting Cyclic Peptide as a Potential Diagnostic Agent for Colorectal Cancer;Molecular Pharmaceutics;2024-06-10

3. Albumin binding improves nanobody pharmacokinetics for dual-modality PET/NIRF imaging of CEACAM5 in colorectal cancer models;European Journal of Nuclear Medicine and Molecular Imaging;2023-05-16

4. Preclinical evaluation of a novel EGFR&c-Met bispecific near infrared probe for visualization of esophageal cancer and metastatic lymph nodes;European Journal of Nuclear Medicine and Molecular Imaging;2023-05-05

5. Identification of a CEACAM5 targeted nanobody for positron emission tomography imaging and near-infrared fluorescence imaging of colorectal cancer;European Journal of Nuclear Medicine and Molecular Imaging;2023-03-14